PASITHEA THERAPEUTICS CORP. Shareholders' Equity
PASITHEA THERAPEUTICS CORP. (KTTA) had Shareholders' Equity of $49.84 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $49.84M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $54.80M; Stockholders' Equity Attributable to Parent as first filed $54.81M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $55.22M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $12.21M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $49.84M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $54.80M 10-Q · filed 2026-08-14 | $54.81M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $55.22M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $12.21M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $15.18M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $12.98M 10-Q · filed 2026-08-14 | |
| 2025-01-01 | $14.78M 10-Q · filed 2025-08-14 | |
| 2024-12-31 | $14.78M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $17.81M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $16.18M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $19.88M 10-Q · filed 2025-11-13 | |
| 2024-01-01 | $23.40M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $23.40M 10-K · filed 2026-03-30 | |
| 2023-09-30 | $28.37M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $35.59M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $39.14M 10-Q · filed 2024-11-13 | $39.14M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $42.50M 10-K · filed 2025-03-24 | |
| 2022-09-30 | $46.79M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $51.32M 10-Q · filed 2023-11-13 | $51.47M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $49.98M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $51.42M 10-K · filed 2024-03-29 | |
| 2021-09-30 | $16.48M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $470.08K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $900.67K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $241.35K 10-K · filed 2023-03-30 | |
| 2020-09-30 | $33.63K 10-Q · filed 2021-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |